1. Home
  2. LION vs MIRM Comparison

LION vs MIRM Comparison

Compare LION & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lionsgate Studios Corp.

LION

Lionsgate Studios Corp.

HOLD

Current Price

$14.81

Market Cap

3.5B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$99.02

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LION
MIRM
Founded
1997
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
5.7B
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
LION
MIRM
Price
$14.81
$99.02
Analyst Decision
Buy
Strong Buy
Analyst Count
9
13
Target Price
$11.89
$119.85
AVG Volume (30 Days)
3.5M
966.1K
Earning Date
05-21-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
74.59
EPS
N/A
N/A
Revenue
$3,195,500,000.00
$19,138,000.00
Revenue This Year
N/A
$26.22
Revenue Next Year
$22.98
$22.04
P/E Ratio
N/A
N/A
Revenue Growth
7.00
N/A
52 Week Low
$5.65
$43.40
52 Week High
$13.03
$114.99

Technical Indicators

Market Signals
Indicator
LION
MIRM
Relative Strength Index (RSI) 80.07 48.48
Support Level $6.26 $97.49
Resistance Level N/A $107.51
Average True Range (ATR) 0.53 6.02
MACD 0.08 -1.04
Stochastic Oscillator 98.48 23.44

Price Performance

Historical Comparison
LION
MIRM

About LION Lionsgate Studios Corp.

Lionsgate Studios Corp is a motion picture and television studio operations aligned with the STARZ premium subscription platform to bring a varied portfolio of entertainment to consumers around the world. The group has two reportable business segments: the Motion Picture and Television Production reportable segments. Motion Picture consists of the development and production of feature films, the acquisition of North American and world-wide distribution rights. Television Production consists of the development, production, and world-wide distribution of television productions, including television series, television movies and mini-series, and non-fiction programming.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: